Send Enquiry

GENVIMAX
Tablets
Packaging and packing Type
Alu Alu | 10x10
MRP :
₹270
PTR :
₹205.71
PTS :
₹185.14
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Iguravib 25 is a tablet formulation from Vibcare Pharma's Genvimax division. Each tablet contains Iguratimod 25 mg. It falls in the immunology and autoimmune group, in the disease-modifying antirheumatic drug (DMARD) class. Iguravib 25 is packed as 10x10 (Alu Alu).
The tablet works through its single ingredient, Iguratimod 25 mg. Iguratimod acts on the body's immune system to bring down the abnormal immune activity seen in rheumatoid arthritis. By lowering this activity, it also reduces the inflammation in and around the joints, which helps limit the joint damage that builds up over time in this condition.
Iguravib 25 is used in the treatment of rheumatoid arthritis in adults and is meant for long-term use under a doctor's supervision. Skin rash and stomach discomfort can occur, and liver enzymes may rise. Serious problems such as low white blood cell counts and lung injury, showing as persistent cough or breathlessness, have been reported; seek prompt medical attention for severe or persistent symptoms.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Iguravib 25 tablets contain Iguratimod 25 mg, a DMARD used in the treatment of rheumatoid arthritis. Main uses: for the treatment of rheumatoid arthritis in adults, as part of long-term disease-modifying therapy; helps to reduce joint inflammation and the joint damage seen in rheumatoid arthritis; used under a doctor's supervision when joint pain and swelling need disease-modifying treatment.
Common side effects of Iguravib 25 Tablet include nausea or vomiting; stomach pain or discomfort; diarrhoea; loss of appetite; skin rash or itching; dizziness or headache. Get medical help at once if you notice yellowing of the skin or eyes, dark urine or other signs of liver injury; low white blood cell count, with repeated or severe infections; breathlessness or cough that does not go away, which may suggest a lung problem.
Each Iguravib 25 tablet contains Iguratimod 25 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Iguravib 25 Tablet only as your doctor advises.
The MRP of Iguravib 25 Tablet is ₹270 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹205.71 and the PTS is ₹185.14.
Each Iguravib 25 tablet contains Iguratimod 25 mg. It comes in a pack of 10x10 (Alu Alu).
The tablet works through its single ingredient, Iguratimod 25 mg. Iguratimod acts on the body's immune system to bring down the abnormal immune activity seen in rheumatoid arthritis. By lowering this activity, it also reduces the inflammation in and around the joints, which helps limit the joint damage that builds up over time in this condition.
Must not be used if you have had an allergic reaction to iguratimod or any of its ingredients. Must not be used during pregnancy. Must not be used by breastfeeding mothers. Check with a doctor first if you have liver or kidney problems. Check with a doctor first if you have an active infection such as tuberculosis, or if you are elderly.
Iguravib 25 Tablet is a brand of Vibcare Pharma, sold through its Genvimax division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner